Log in

NASDAQ:AMRI - Albany Molecular Research Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$21.74
0.00 (0.00 %)
(As of 09/1/2017)
Add
Today's Range
$21.74
Now: $21.74
$21.74
50-Day Range
$21.74
MA: $21.74
$21.74
52-Week Range
$13.01
Now: $21.74
$22.17
VolumeN/A
Average Volume872,120 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Albany Molecular Research, Inc is a contract research and manufacturing company. The Company operates through Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP) and Fine Chemicals (FC) segments. The DDS segment includes activities, such as drug lead discovery, optimization, drug development and small scale commercial manufacturing. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:AMRI
CUSIPN/A
Phone+1-518-4640279

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive AMRI News and Ratings via Email

Sign-up to receive the latest news and ratings for AMRI and its competitors with MarketBeat's FREE daily newsletter.


Albany Molecular Research (NASDAQ:AMRI) Frequently Asked Questions

What is Albany Molecular Research's stock symbol?

Albany Molecular Research trades on the NASDAQ under the ticker symbol "AMRI."

How were Albany Molecular Research's earnings last quarter?

Albany Molecular Research, Inc. (NASDAQ:AMRI) issued its quarterly earnings data on Tuesday, May, 10th. The biotechnology company reported $0.07 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.21 by $0.14. The biotechnology company earned $102.80 million during the quarter, compared to analysts' expectations of $107.20 million. View Albany Molecular Research's Earnings History.

Has Albany Molecular Research been receiving favorable news coverage?

Media coverage about AMRI stock has trended extremely negative on Monday, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Albany Molecular Research earned a media sentiment score of -4.5 on InfoTrie's scale. They also gave media coverage about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Albany Molecular Research.

What other stocks do shareholders of Albany Molecular Research own?

Who are Albany Molecular Research's key executives?

Albany Molecular Research's management team includes the folowing people:
  • William S. Marth, President, Chief Executive Officer, Director
  • Felicia Ladin, Chief Financial Officer, Senior Vice President, Treasurer
  • Lori M. Henderson Esq., Senior Vice President, General Counsel, Secretary
  • Christopher M Conway, Senior Vice President - Discovery and Development and Global Commercial Sales
  • , Bio & Compensation - 
  • Milton Boyer, Senior Vice President - Drug Product Manufacturing
  • , Bio & Compensation - 
  • Steven R. Hagen Ph.D., Senior Vice President - Manufacturing and Pharmaceuticals
  • George Svokos, Chief Commercial Officer and Senior Vice President, API
  • Jimmy Wang Ph.D., Chief Information Officer
  • , Bio & Compensation - 
  • Thomas E. D' Ambra Ph.D., Non-Executive Chairman of the Board
  • David H. Deming, Director

What is Albany Molecular Research's stock price today?

One share of AMRI stock can currently be purchased for approximately $21.74.

What is Albany Molecular Research's official website?

The official website for Albany Molecular Research is http://www.amriglobal.com/.

How can I contact Albany Molecular Research?

Albany Molecular Research's mailing address is 21 Corporate Cir, PO Box 15098, ALBANY, NY 12203-5154, United States. The biotechnology company can be reached via phone at +1-518-4640279.


MarketBeat Community Rating for Albany Molecular Research (NASDAQ AMRI)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  234 (Vote Outperform)
Underperform Votes:  173 (Vote Underperform)
Total Votes:  407
MarketBeat's community ratings are surveys of what our community members think about Albany Molecular Research and other stocks. Vote "Outperform" if you believe AMRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: What are gap-down stocks?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel